معرفی
Professor Fasseli Coulibaly is a leading academic at Monash University's Monash Biomedicine Discovery Institute, affiliated with the Department of Biochemistry & Molecular Biology. His research focuses on structural virology, X-ray crystallography, and molecular virology, with a strong emphasis on developing stable viral vaccine platforms and understanding viral mechanisms. He holds a Professorship and leads multiple high-impact projects funded by organizations like the Bill and Melinda Gates Foundation.
Key research interests include viral architecture, protein crystallization for vaccine delivery, hepatitis C and smallpox antivirals, and applications in developing countries. His work bridges structural biology with practical medical solutions, leveraging techniques like synchrotron-based X-ray crystallography and cryo-EM. Notable collaborations include partnerships with the Burnet Institute and the Australian Synchrotron.
Recent articles highlight advancements in viral nucleocapsid architecture, poxvirus core structure, and SARS-CoV-2 spike glycoprotein stability. Awards include the 2021 Monash BDI Innovation in Learning and Teaching Award. His projects span antiviral drug design, flavivirus structural vaccinology, and SARS-CoV-2 inhibitors. Fasseli's work contributes to UN Sustainable Development Goals, particularly in health and global equity.
Labs and teams include leadership in the Monash Antimicrobial Resistance Group and roles in interdisciplinary collaborations. His research has been featured in journals like Cell, Nature Structural & Molecular Biology, and PLoS Pathogens.
